Colin McKinlay, PhDSenior Director, Chemistry and Delivery Technology at Nutcracker TherapeuticsSpeaker
Profile
Dr. Colin McKinlay is the senior director of chemistry and delivery technologies at Nutcracker Therapeutics. He has significant expertise in nucleic acid delivery through his doctoral research at Stanford University with professors Paul Wender and Robert Waymouth. Colin’s research involved preparation of synthetic delivery vehicles through organocatalytic ring-opening polymerization; their characterization; and in vitro and in vivo evaluation for the delivery of DNA, RNA, and other biological macromolecules. He holds over five patents and has nine peer-reviewed publications on chemical delivery technologies. Colin has led the delivery efforts at Nutcracker Therapeutics since 2018, including the establishment of its unique peptoid-based Nutshell® delivery platform.
Agenda Sessions
mRNA Manufacturing on the NMU-SymphonyTM - A Rapid End-to-end Platform for the Design, Microfluidic Synthesis, and Delivery of Personalized Cancer Therapeutics
, 1:30pmView Session